{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:01:43Z","timestamp":1789354903120,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.urolonc.2025.12.001","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T20:34:57Z","timestamp":1767386097000},"page":"110965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Artificial intelligence in diagnostic, prognostic, and predictive genomic biomarkers for prostate cancer: Ready for prime time?"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-4851","authenticated-orcid":false,"given":"Andrey","family":"Bazarkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4369-173X","authenticated-orcid":false,"given":"Mark","family":"Taratkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Vovdenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Androsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Balashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Itskevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenii","family":"Bezrukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenii","family":"Shpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Glybochko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.12.001_bib0001","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacr.2019.06.004","article-title":"A survey of deep-learning applications in ultrasound: artificial intelligence\u2013Powered ultrasound for improving clinical workflow","volume":"16","author":"Akkus","year":"2019","journal-title":"J Am College Radiol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13645706.2019.1575882","article-title":"Introduction to artificial intelligence in medicine","volume":"28","author":"Mintz","year":"2019","journal-title":"Minimal Invasive Therapy Allied Technol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/j.ajkd.2019.05.020","article-title":"Artificial Intelligence in nephrology: core concepts, clinical applications, and perspectives","volume":"74","author":"Niel","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41391-023-00673-3","article-title":"A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading","volume":"26","author":"Morozov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41588-018-0295-5","article-title":"A primer on deep learning in genomics","volume":"51","author":"Zou","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.788300","article-title":"Protein science meets artificial intelligence: a systematic review and a biochemical meta-analysis of an inter-field","author":"Villalobos-Alva","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0007","doi-asserted-by":"crossref","first-page":"102589","DOI":"10.1016\/j.artmed.2023.102589","article-title":"Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: a systematic review of epigenome-wide studies","volume":"143","author":"Yuan","year":"2023","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0008","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gene.2019.04.062","article-title":"Machine learning technology in the application of genome analysis: a systematic review","volume":"705","author":"Wu","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ebiom.2018.05.010","article-title":"RankProd combined with genetic algorithm optimized artificial neural network establishes a diagnostic and prognostic prediction model that revealed C1QTNF3 as a biomarker for prostate cancer","volume":"32","author":"Hou","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0010","doi-asserted-by":"crossref","unstructured":"H Dong, X Wang, Identification of signature genes and construction of an artificial neural network model of prostate cancer, 2022, 2022, doi: 10.1155\/2022\/1562511.","DOI":"10.1155\/2022\/1562511"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0011","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1093\/bioinformatics\/btac343","article-title":"Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks","volume":"38","author":"Weitz","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/1460458221989402","article-title":"Feature selection with ensemble learning for prostate cancer diagnosis from microarray gene expression","volume":"27","author":"Gumaei","year":"2021","journal-title":"Health Informatics J"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0013","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1158\/0008-5472.CAN-20-1791","article-title":"A deep learning framework identifies pathogenic noncoding somatic mutations from personal prostate cancer genomes","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0014","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ebiom.2018.05.010","article-title":"RankProd combined with genetic algorithm optimized artificial neural network establishes a diagnostic and prognostic prediction model that revealed C1QTNF3 as a biomarker for prostate cancer","volume":"32","author":"Hou","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0015","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.ygeno.2020.06.035","article-title":"Bioinformatics analysis of the genes involved in the extension of prostate cancer to adjacent lymph nodes by supervised and unsupervised machine learning methods: the role of SPAG1 and PLEKHF2","volume":"112","author":"Shamsara","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0016","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-021-03922-4","article-title":"Biologically informed deep neural network for prostate cancer discovery","volume":"598","author":"Elmarakeby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0017","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/onco.13869","article-title":"Identification of somatic gene signatures in circulating cell-free DNA associated with disease progression in metastatic prostate cancer by a novel machine learning platform","volume":"26","author":"Lin","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-7-47","article-title":"Constructing higher-order miRNA-mRNA interaction networks in prostate cancer via hypergraph-based learning","volume":"7","author":"Kim","year":"2013","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08021-1","article-title":"Reference-free transcriptome signatures for prostate cancer prognosis","volume":"21","author":"Nguyen","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786828","article-title":"Prostate cancer: early detection and assessing clinical risk using deep machine learning of high dimensional peripheral blood flow cytometric phenotyping data","volume":"12","author":"Cosma","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267714","article-title":"Discriminatory Gleason grade group signatures of prostate cancer: an application of machine learning methods","volume":"17","author":"Mokoatle","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04633-2","article-title":"Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer","volume":"21","author":"Zhu","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0023","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2018.01.054","article-title":"Machine learning on a genome-wide association study to predict late genitourinary toxicity after prostate radiation therapy","volume":"101","author":"Lee","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21165847","article-title":"Deep learning modeling of androgen receptor responses to prostate cancer therapies","volume":"21","author":"Snow","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0025","article-title":"A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-015-0864-1","article-title":"Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients","volume":"17","author":"Lallous","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0027","doi-asserted-by":"crossref","first-page":"37747","DOI":"10.1074\/jbc.M507464200","article-title":"Structural basis for accommodation of nonsteroidal ligands in the androgen receptor","volume":"280","author":"Bohl","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0028","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1078-0432.CCR-12-2910","article-title":"Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer","volume":"19","author":"Hoffman-Censits","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0029","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14656566.2013.775251","article-title":"Enzalutamide for the treatment of prostate cancer","volume":"14","author":"Pal","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0030","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1073\/pnas.0500381102","article-title":"Structural basis for antagonism and resistance of bicalutamide in prostate cancer","volume":"102","author":"Bohl","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0031","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-11-3948","article-title":"ARN-509: a novel antiandrogen for prostate cancer treatment","volume":"72","author":"Clegg","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0032","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clgc.2018.07.017","article-title":"Clinical development of darolutamide: a novel androgen receptor antagonist for the treatment of prostate cancer","volume":"16","author":"Fizazi","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0033","doi-asserted-by":"crossref","first-page":"153109","DOI":"10.1016\/j.prp.2020.153109","article-title":"Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis","volume":"216","author":"Wu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8430485","article-title":"Discovering gene signature shared by prostate cancer and neurodegenerative diseases based on the bioinformatics approach","volume":"2022","author":"Su","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/bjc.1998.695","article-title":"Possible relationship of the apolipoprotein E (ApoE) epsilon4 allele to prostate cancer","volume":"78","author":"Lehrer","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0036","first-page":"707","article-title":"Apolipoprotein E genotypes in patients with prostate cancer","volume":"36","author":"Yencilek","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0037","first-page":"1","article-title":"Diagnostic ability of dynamic contrast-enhanced Magnetic resonance imaging for prostate cancer and clinically significant prostate cancer in equivocal lesions: a systematic review and meta-analysis","volume":"11","author":"Zeng","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0038","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajur.2022.05.003","article-title":"Artificial intelligence for renal cancer: from imaging to histology and beyond","volume":"9","author":"Kowalewski","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133318","article-title":"Artificial intelligence compared to radiologists for the initial diagnosis of prostate cancer on magnetic resonance imaging: a systematic review and recommendations for future studies","volume":"13","author":"Syer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060983","article-title":"More than meets the eye: using textural analysis and artificial intelligence as decision support tools in prostate cancer diagnosis-A systematic review","volume":"12","author":"Telecan","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-022-01199-3","article-title":"Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review","volume":"13","author":"Sushentsev","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diii.2022.11.005","article-title":"Artificial intelligence algorithms aimed at characterizing or detecting prostate cancer on MRI: how accurate are they when tested on independent cohorts? - A systematic review","volume":"104","author":"Rouvi\u00e8re","year":"2023","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12040799","article-title":"Current value of biparametric prostate MRI with machine-learning or deep-learning in the detection, grading, and characterization of prostate cancer: a systematic review","volume":"12","author":"Michaely","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0044","doi-asserted-by":"crossref","DOI":"10.1186\/s41747-022-00282-0","article-title":"Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics","volume":"6","author":"Liberini","year":"2022","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0045","article-title":"Don\u2019t fear the artificial intelligence: a systematic review of machine learning for prostate cancer detection in pathology","author":"Frewing","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urolonc.2025.12.001_bib0046","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:16:21Z","timestamp":1771431381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1078143925004880"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence in diagnostic, prognostic, and predictive genomic biomarkers for prostate cancer: Ready for prime time?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110965"}}